New BIO chairwoman: Biotechnology has proud story to tell

04/29/2013 | Washington Post, The

The biotechnology sector needs to share its health care accomplishments with consumers and lawmakers, highlighting the contributions it makes through drug development, newly elected BIO chairwoman Rachel King said. "Most people have probably benefited or know someone who has benefited. We need to communicate, as part of that, that to get to those new medicines takes a long time and a lot of investment," she said. King, the president and CEO of GlycoMimetics, said the FDA's efforts to hasten the approval process are crucial for limiting investor uncertainty and bringing new drugs to patients.

View Full Article in:

Washington Post, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC